CVS Health Corp.
Healthcare / Pharmacy RetailFounded 1963- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
CVS Health Corp.
Company History
Founded 1963 in Woonsocket, Rhode Island
Last reviewed: 2025-07-15 · By Swet Parvadiya
Originally founded in 1963 in Lowell, Massachusetts as Consumer Value Stores — selling health and beauty products without pharmacy services — CVS didn't add prescription dispensing until the 1970s. Prescription drugs weren't part of the original model.
Stanley Goldstein co-founded Consumer Value Store in 1963 in Lowell, Massachusetts, alongside Sidney Goldstein and Ralph Hoagland, operating under the Melville Corporation conglomerate structure. He served in senior leadership roles through CVS's critical formative decades, overseeing the chain's expansion from a single New England value store into a regional retail pharmacy presence with hundreds of locations. Goldstein's most enduring contribution was articulating a retail identity for CVS that differentiated it from traditional full-service drugstores through a focus on consumer value and product selection, a positioning that proved durable through multiple decades of competitive evolution. His tenure laid the organizational and cultural foundation upon which later executives would build the acquisitive growth strategy that transformed CVS into a national chain. Goldstein eventually served as CEO before transitioning leadership to executives who would pursue the national expansion and vertical integration strategies that define CVS Health's modern identity.
Sidney Goldstein joined Stanley Goldstein and Ralph Hoagland in founding Consumer Value Store in Lowell, Massachusetts, in 1963. Operating as a subsidiary of the Melville Corporation, the founding team developed a retail health and beauty concept that distinguished itself from the apothecary-style drugstores of the era through aggressive value pricing and broad product selection. Sidney Goldstein's contributions were integral to establishing CVS's operational identity in its first decade of existence, helping the company navigate the competitive landscape of New England retail during a period when national drugstore chains were beginning to assert significant competitive pressure. The founding team's decision to position CVS as a consumer value retailer rather than a traditional pharmacy created the brand identity that would persist, in modified form, through the company's transformation into a healthcare services giant.
Ralph Hoagland co-founded Consumer Value Store with Stanley Goldstein and Sidney Goldstein in 1963, establishing one of the retail concepts that would eventually grow into the largest integrated healthcare company in the United States. Operating under the Melville Corporation umbrella, Hoagland contributed to the early strategic and operational definition of CVS as a value-oriented health and beauty retailer targeting cost-conscious consumers in the northeastern United States. The founding team's shared vision — that there was a meaningful market gap for a consumer-focused, price-competitive health and personal care retailer — proved prescient as CVS grew through organic expansion and acquisitions in subsequent decades. Hoagland's early contribution is best understood as establishing the consumer value identity that gave CVS a clear competitive positioning in a crowded retail market, an identity that the company would later expand far beyond its original boundaries through vertical healthcare integration.
Stanley Goldstein, Sidney Goldstein, and Ralph Hoagland open the first Consumer Value Store in Lowell, Massachusetts, as a subsidiary of the Melville Corporation. The store sells health and beauty products without pharmacy dispensing services, introducing a value-oriented retail concept to New England consumers.
CVS expands into prescription pharmacy services, adding licensed pharmacists and dispensing capabilities to its store format. This strategic addition transforms CVS from a health and beauty retailer into a full-service drugstore competitor, fundamentally changing the company's economic model and positioning.
CVS acquires Peoples Drug, a chain of approximately 490 stores primarily located in the Mid-Atlantic states including Virginia, Maryland, and the Washington D.C. Metropolitan area. The acquisition roughly doubles CVS's store count and establishes the company's presence in major markets outside its New England stronghold.
CVS separates from its parent company, the Melville Corporation, and becomes an independent publicly traded company listed on the New York Stock Exchange under the ticker symbol CVS. The separation gives CVS full control over its capital allocation and strategic direction for the first time in its corporate history.
CVS acquires Revco Drug Stores, a Midwestern chain with approximately 2,500 locations, in what was at the time the largest drugstore acquisition in American history. The deal expands CVS's geographic presence into Ohio, Michigan, Indiana, and other Midwestern states, transforming it from a northeastern regional chain into a national pharmacy competitor.
CVS acquires MinuteClinic, an innovative walk-in clinic concept that operates inside CVS Pharmacy locations. MinuteClinic introduces a nurse practitioner-staffed acute care model that allows patients to receive treatment for common conditions without a physician appointment, positioning CVS as a primary care access point for the first time.
CVS completes a landmark merger with Caremark Rx, one of the largest pharmacy benefit managers in the United States, creating CVS Caremark Corporation. The deal, valued at approximately $26.5 billion, gives CVS control over PBM operations processing hundreds of millions of prescriptions and transforms the company from a retail pharmacy chain into an integrated pharmacy services company.
CVS voluntarily removes all tobacco products from its approximately 7,600 stores, forfeiting an estimated $2 billion in annual tobacco revenues. Simultaneously, the company renames itself CVS Health Corporation, signaling a strategic identity shift from pharmacy retailer to healthcare company. This decision becomes one of the most discussed corporate brand strategy moves in American retail history.
CVS Health completes the acquisition of Aetna Inc. For approximately $69 billion — the largest healthcare deal in U.S. History at the time. The acquisition adds one of America's oldest and largest health insurers to CVS's portfolio, giving the company coverage of approximately 22 million medical members and establishing the insurance pillar of its integrated healthcare strategy.
CVS Health acquires Oak Street Health, a primary care network serving Medicare patients in urban and underserved communities, for approximately $10.6 billion. Oak Street operates value-based care centers where clinical teams receive capitated payments to manage patients' total health, and its 188-plus locations give CVS a physical primary care presence that complements MinuteClinic's acute care focus.
Elevated medical utilization drives Aetna's Medicare Advantage business into significant underwriting losses, forcing multiple downward revisions to CVS Health's earnings guidance throughout the year. In October 2024, CEO Karen Lynch departs the company and is replaced by David Joyner, a longtime CVS executive and Caremark specialist, marking a significant leadership and strategic recalibration.
Under CEO David Joyner, CVS Health announces a strategic refocus on operational integration over acquisition-driven expansion, including deliberate reduction of Medicare Advantage enrollment to improve underwriting margins and accelerated effort to demonstrate clinical and financial outcomes from the company's integrated healthcare model.
CVS merged with Caremark Rx, one of the United States' largest pharmacy benefit managers, to gain control over a critical link in the pharmaceutical distribution chain. The deal was defensive and offensive simultaneously — defensive in that PBM power over retail pharmacy reimbursement rates was threatening CVS's core business economics, and offensive in that owning a major PBM would give CVS access to prescription volume and employer relationships that retail pharmacy alone could not generate. The transaction created CVS Caremark Corporation, one of the largest healthcare companies in the U.S. By revenue at the time.
CVS acquired MinuteClinic, a walk-in clinic operator staffed by nurse practitioners providing acute and preventive care services, to establish a clinical care capability within its retail pharmacy footprint. The acquisition was strategically prescient — it gave CVS the infrastructure to offer healthcare services beyond prescription dispensing, positioning the company as a primary care access point for patients seeking convenient, affordable alternatives to traditional physician office visits. MinuteClinic's model aligned naturally with CVS's retail pharmacy traffic patterns and high-volume, appointment-free service model.
CVS's acquisition of Aetna, America's third-largest health insurer at the time, was the defining strategic move of the company's modern era and the largest healthcare acquisition in U.S. History. The deal was driven by the belief that owning an insurance company would give CVS both a captive customer base for its pharmacy and PBM services and the ability to align financial and clinical incentives across the full healthcare journey of millions of members. CVS's leadership argued that Aetna's insurance economics and CVS's pharmacy and clinical capabilities were mutually reinforcing — reducing medical costs through better medication management, care coordination, and preventive services.
CVS acquired Oak Street Health to establish a value-based primary care capability specifically designed for Medicare patients, adding a critical clinical layer to its integrated healthcare model. Oak Street's differentiated approach — serving Medicare patients in underserved urban communities through a capitated, outcomes-focused primary care model — complemented Aetna's Medicare Advantage insurance operations and Caremark's pharmacy benefit management by providing the primary care coordination function that CVS had lacked. The acquisition was intended to demonstrate that CVS's integrated model could genuinely reduce total medical costs by keeping high-risk patients healthier through proactive primary care.
CVS acquired Peoples Drug, an approximately 490-store chain concentrated in the Mid-Atlantic region, to extend its pharmacy retail footprint beyond New England into the Washington D.C. Metropolitan area and surrounding markets. The acquisition represented CVS's first major geographic expansion outside its northeastern stronghold and established the acquisition-led growth playbook that would define CVS's retail pharmacy strategy through the 1990s and into the 2000s.
CVS was founded in 1963 by brothers Stanley and Sidney Goldstein with partner Ralph Hoagland as Consumer Value Stores in Lowell, Massachusetts, originally operating health and beauty discount stores supporting modest regional expansion through 1960s-1970s. The company expanded systematically through 1980s-1990s including 1972 acquisition of pharmacy operations transforming Consumer Value Stores into drug store retailer, the 1990 Melville Corporation parent company restructuring eventually divesting various non-pharmacy operations including Marshalls (1995), Bob's Stores, and other retail concepts, with continued strategic focus on CVS pharmacy operations. Major M&A activity through 2000s-2010s included 2004 Eckerd pharmacy acquisition ($2.15B), 2006 MinuteClinic acquisition (retail clinic operations), 2007 Caremark Rx ($26.5B for pharmacy benefit management), 2014 dropping cigarette sales becoming CVS Health, and transformational 2018 Aetna acquisition ($69 billion creating integrated healthcare company). Revenue grew from $2 billion (1990) to $372 billion (2024).
CVS Health became the first major US drug store chain to stop selling tobacco products in October 2014, removing all cigarettes, cigars, and other tobacco products from approximately 7,800 stores nationwide despite estimated $2 billion annual revenue impact. Strategic rationale combined corporate identity transformation toward healthcare company positioning (rebranding from CVS Caremark to CVS Health concurrent with tobacco exit), recognition that tobacco sales conflicted with healthcare mission, and various other strategic considerations. The tobacco exit decision generated significant industry recognition and customer response, with research showing 1% reduction in adult smoking rates in states with high CVS market presence in following years suggesting public health impact. Strategic positioning continues healthcare focus through MinuteClinic retail clinics, HealthHUB store reconfiguration supporting various health services, and continued pharmacy operations expansion. The tobacco exit represents continued cultural emphasis on healthcare mission versus pure retail focus, with continued strategic moves reinforcing healthcare company identity.
CVS Health acquired Aetna Inc. in November 2018 for $69 billion creating vertically integrated healthcare company combining CVS's retail pharmacy operations, Caremark pharmacy benefit management, and Aetna's health insurance operations serving 39+ million members. Strategic rationale included healthcare industry vertical integration supporting various cost savings and operational efficiencies, increased customer touchpoints across pharmacy and insurance interactions, data integration supporting various healthcare insights, and various other strategic priorities. Post-acquisition integration has faced multiple challenges including operational complexity managing diverse healthcare operations, continued cost pressures in Medicare Advantage business through Aetna operations, regulatory oversight from various healthcare-specific regulations, and various other operational considerations. Strategic value continues developing through ongoing integration period with continued operational improvements supporting consolidated business performance, though continued financial challenges in Medicare Advantage during 2024 have generated significant operational pressure. Future strategic execution depends on continued operational performance through various competitive dynamics.
CVS Health experienced significant 2024 financial difficulties primarily through Medicare Advantage business challenges at Aetna subsidiary, with elevated medical loss ratios (medical costs exceeding initial pricing assumptions) generating substantial earnings shortfall versus prior expectations. Specific challenges include continued Medicare Advantage utilisation increases beyond actuarial assumptions, regulatory rate changes affecting Medicare Advantage pricing, continued competitive intensity affecting market share, and various other operational factors. Subsequent CEO transition (Karen Lynch replaced by David Joyner in October 2024) reflected continued operational challenges requiring fresh strategic perspective. Strategic responses include continued Medicare Advantage pricing actions supporting 2025 financial performance recovery, operational improvements across various healthcare segments, capital allocation discipline supporting continued strategic investment, and various other strategic initiatives. The 2024 challenges affect stock performance significantly with continued investor concerns about strategic positioning through ongoing healthcare industry dynamics. Future financial performance depends on continued operational execution and Medicare Advantage business improvement.